Figure 1. Relationships between reperfusion and favorable clinical response in patients with the Target Mismatch, the Malignant and the No Mismatch profiles.
FCR indicates favorable clinical response, defined as a National Institutes of Health Stroke Scale score of 0–1 at day 90 or an improvement of ≥8 points on the NIHSS score between baseline and day 90. The forest plots demonstrate that reperfusion is associated with favorable clinical response in Target Mismatch patients (top), but not in patients with the Malignant (middle) and No Mismatch (bottom) profiles.